search
Back to results

IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men

Primary Purpose

Human Immunodeficiency Virus

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
IMB
Sponsored by
Medical College of Wisconsin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Human Immunodeficiency Virus focused on measuring HIV testing, HIV pre-exposure prophylaxis

Eligibility Criteria

17 Years - 24 Years (Child, Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. 17-24 years old;
  2. Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months;
  3. Resident of the US based on home address;
  4. HIV-negative or unknown status based on self-report; and
  5. Self-reported risk for HIV (based on CDC criteria for PrEP use) defined as reporting any of the following in the past six months:

    1. Bacterial STI
    2. Condomless anal sex (CAS) with a casual male sexual partner
    3. CAS with an HIV-positive or unknown status main partner
    4. CAS with an HIV-negative main partner who reports CAS with other male partners.

Exclusion Criteria:

  1. Current PrEP use;
  2. Unstable, serious psychiatric symptoms;
  3. Currently suicidal/homicidal; and
  4. Evidence of gross cognitive impairment.

Sites / Locations

  • Medical College of Wisconsin

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

IMB

No Intervention

Arm Description

Individuals randomized to this arm will receive a behavioral intervention based on the Information-Motivation-Behavior (IMB) model designed to increase HIV self-testing, among other protective behaviors.

Individuals randomized to this arm will receive no intervention.

Outcomes

Primary Outcome Measures

Change in the number of self-reported HIV self-tests
Self-reported self-administration of HIV testing within the past 3 months (i.e., since baseline assessment).

Secondary Outcome Measures

Full Information

First Posted
April 26, 2021
Last Updated
October 18, 2023
Sponsor
Medical College of Wisconsin
search

1. Study Identification

Unique Protocol Identification Number
NCT04865341
Brief Title
IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men
Official Title
Optimizing an IMB-guided Intervention to Support HIV Self-testing and PrEP Uptake Among YMSM: A Pilot Factorial RCT
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 1, 2023 (Anticipated)
Primary Completion Date
July 31, 2024 (Anticipated)
Study Completion Date
July 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical College of Wisconsin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The proposed study will involve adolescent (17-24 years old) men who have sex with men (described as YMSM hereafter) who meet eligibility criteria to participate in each study. Prospective study candidates will receive a copy of the IRB-approved informed consent forms and, if they choose to participate, will provide consent before enrollment into this study. Involvement of human subjects is detailed in the Research Strategy portion of this proposal, Recruitment and Retention Plan, and Protection of Human Subjects sections. Briefly, investigators will develop and pilot a randomized controlled trial (RCT) to support HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP) uptake. Intervention content will be focused on constructs of the Information-Motivation-Behavioral Skills (IMB) model. To reduce cost and increase feasibility, investigators plan to incorporate previously developed content as much as possible-investigators see integration of this content as a major strength. Investigators will include professionally produced videos about HIV testing and PrEP and other resources including the geo-targeted directories to find clinic settings that offer HIV testing and PrEP, all of which are publicly available. Investigators believe our approach of guiding YMSM through intervention modules based on theory will help improve content retention/use and ultimately influence constructs posited to result in behavior change. Investigators foresee using multiple forms of attention-matched material, media, and programming to engage (and retain engagement) of YMSM throughout the brief single-session intervention (45-60 minutes). Intervention content is subject to change depending on feedback from focus groups, survey results, YAB feedback, and usability testing. Primary endpoints of this study include HIVST and PrEP uptake, including stage of change towards HIVST and PrEP uptake. Secondary outcomes include changes in IMB model indicators (e.g., HIV prevention knowledge).
Detailed Description
The research activity designated as a clinical trial is our pilot RCT where investigators will then enroll 120 YMSM and randomly assign individuals to one of four experimental groups: (1) information-only (I), (2) information + motivation (IM), (3) information + behavioral skills (IB), and (4) full IMB model (IMB). Randomization will be blinded using Qualtrics, and randomization will occur in a ratio of 1:1:1:1 between the four groups. Individuals assigned to groups 1-3 will receive attention-matched information-only filler content (e.g., information about physical activity and diet), but note that group (1) information-only will still receive HIVST and PrEP related information; attention-matched filler content will cover the one or two theoretical sections excluded from that condition arm. Intervention content will be based upon the formative research, but preliminary content is identified in Table 4 of the Research Strategy. After completion of the baseline survey, randomization, and intervention, participants will be followed for a period of three months. Individuals will be surveyed at 1- and 3-months post intervention to assess our primary endpoints of HIVST and PrEP uptake. Preliminary impact will be assessed using within- and between-subjects analyses. First, investigators will test the performance of randomization by chi-squared comparisons and ANOVAs for categorical and continuous variables, respectively. Second, investigators will test for differential attrition by treatment group at 1- and 3-month follow-up assessments. Third, investigators will assess post-intervention HIV testing and PrEP uptake using factorial logistic regressions to determine between-group differences, adjusting for any breakdowns in randomization or differential attrition. Fourth, investigators will test for changes in stage of change indicators by randomized group, time, and group*time interaction, with similar adjustment procedures, using GEE; this analysis will help us determine a trend towards HIVST or PrEP uptake were investigators to extend the length of follow-up. Power: Our study has 80% power to detect a ½ stage average difference (d = 0.68; α = 0.05) on the PrEP cascade comparing the three experimental groups combined to the information-only control assuming 80% retention. As the purpose of this study is to pilot the RCT, investigators have not powered this study to determine differences by each experimental group compared to the control group (which is planned for the full RCT in a future R01). Finally, investigators will conduct within-subjects tests comparing baseline and follow-up IMB construct scale scores stratified by group as an evaluation of internal validity (i.e., did the interventions have an effect on the targeted constructs?).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Human Immunodeficiency Virus
Keywords
HIV testing, HIV pre-exposure prophylaxis

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
132 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
IMB
Arm Type
Experimental
Arm Description
Individuals randomized to this arm will receive a behavioral intervention based on the Information-Motivation-Behavior (IMB) model designed to increase HIV self-testing, among other protective behaviors.
Arm Title
No Intervention
Arm Type
No Intervention
Arm Description
Individuals randomized to this arm will receive no intervention.
Intervention Type
Behavioral
Intervention Name(s)
IMB
Intervention Description
Intervention content will be focused on the Information-Motivation-Behavioral Skills (IMB) model. We plan to incorporate previously developed content as much as possible and will include professionally produced videos about HIV testing and PrEP and other resources. We believe our approach of guiding YMSM through intervention modules based on theory will help improve content retention/use and ultimately influence constructs posited to result in behavior change. We foresee using multiple forms of attention-matched material, media, and programming to engage (and retain engagement) of YMSM throughout the brief single-session intervention (45-60 minutes).
Primary Outcome Measure Information:
Title
Change in the number of self-reported HIV self-tests
Description
Self-reported self-administration of HIV testing within the past 3 months (i.e., since baseline assessment).
Time Frame
3 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 17-24 years old; Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months; Resident of the US based on home address; HIV-negative or unknown status based on self-report; and Self-reported risk for HIV (based on CDC criteria for PrEP use) defined as reporting any of the following in the past six months: Bacterial STI Condomless anal sex (CAS) with a casual male sexual partner CAS with an HIV-positive or unknown status main partner CAS with an HIV-negative main partner who reports CAS with other male partners. Exclusion Criteria: Current PrEP use; Unstable, serious psychiatric symptoms; Currently suicidal/homicidal; and Evidence of gross cognitive impairment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Steven A John, MPH, PhD
Phone
414-955-7700
Email
sjohn@mcw.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven A John, MPH, PhD
Organizational Affiliation
Medical College of Wisconsin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical College of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven A John, MPH, PhD
Phone
414-955-7700
Email
sjohn@mcw.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
32495242
Citation
John SA, Lopez-Rios J, Starks TJ, Rendina HJ, Grov C. Willingness to Distribute HIV Self-Testing Kits to Recent Sex Partners Among HIV-Negative Gay and Bisexual Men and an Examination of Free-Response Data from Young Men Participating in the Nationwide Cohort. Arch Sex Behav. 2020 Aug;49(6):2081-2089. doi: 10.1007/s10508-020-01752-5. Epub 2020 Jun 3.
Results Reference
background
PubMed Identifier
32433680
Citation
John SA, Walsh JL, Quinn KG, Cho YI, Weinhardt LS. Testing the Interpersonal-Behavior model to explain intentions to use patient-delivered partner therapy. PLoS One. 2020 May 20;15(5):e0233348. doi: 10.1371/journal.pone.0233348. eCollection 2020.
Results Reference
background
PubMed Identifier
32300991
Citation
John SA, Quinn KG, Pleuhs B, Walsh JL, Petroll AE. HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers. AIDS Behav. 2020 Nov;24(11):3124-3131. doi: 10.1007/s10461-020-02866-6.
Results Reference
background
PubMed Identifier
32240437
Citation
Quinn KG, Zarwell M, John SA, Christenson E, Walsh JL. Perceptions of PrEP Use Within Primary Relationships Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men. Arch Sex Behav. 2020 Aug;49(6):2117-2128. doi: 10.1007/s10508-020-01683-1. Epub 2020 Apr 2.
Results Reference
background
PubMed Identifier
32109141
Citation
Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28.
Results Reference
background

Learn more about this trial

IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men

We'll reach out to this number within 24 hrs